Aerobic exercise has been linked with Parkinson's disease progression and risk. ( Washington Post) Air purifiers in residential aged-care facilities did not reduce the incidence of acute respiratory ...

The US FDA has cleared an investigational new drug (IND) application for HG202, by HuidaGene Therapeutics. This drug is the ...

This drug is the world’s first-ever CRISPR/Cas13 RNA-editing therapy for clinical use in treating neovascular age-related macular degeneration (nAMD). The US FDA has cleared an investigational new ...

Following the clearance of an investigational new drug application from the FDA, a phase 1 trial will examine the novel ...

A new drug application is planned for early 2025 for the indications ... results of p-value of less than 0.0001 for both doses tested. We expect to file an IND application for psoriasis with the FDA ...

AK132 is a bispecific antibody developed by Akeso, targeting the recombinant humanized Claudin18.2 (CLDN18.2) splice variant 2 and CD47 for the treatment of various cancers, including gastric, ...

Multiple myeloma is the second most common hematologic malignancy, but there is a treatment gap for patients with disease ...

HuidaGene Therapeutics gets US FDA clearance for CRISPR/Cas13 RNA-editing HG202 for macular degeneration: Shanghai Tuesday, November 5, 2024, 09:00 Hrs [IST] HuidaGene Therapeutic ...

Multiple players are exploring whether modalities designed to combat B cell malignancies can be repurposed against lupus, ...

NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage global leader in broad-spectrum antiviral nanomedicines, today announces that Anil R. Diwan, Ph.D., the Company’s President ...

In recent years, the advent of quantum technology has revolutionized numerous fields, leading to groundbreaking innovations in computation, cryptography, and ma ...